Company Snapshot
1101 Raintree Circle
Allen, TX 75013
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 4
Please select from the dropdown
Company Financials

2008
2009
2010
Gross Profit
$5,687
$14,708
$36,968
Operating Income
-$63,356
-$935,412
-$2,875,056
Net Income
-$63,356
-$969,788
-$7,513,915
2008
Gross Profit
$5,687
Operating Income
-$63,356
Net Income
-$63,356
2009
Gross Profit
$14,708
Operating Income
-$935,412
Net Income
-$969,788
2010
Gross Profit
$36,968
Operating Income
-$2,875,056
Net Income
-$7,513,915
The above data on Enzolytics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Chairman of the Board and Interim President
$20,833
$973,576
$0
$994,409
$994,409
Chairman of the Board and Interim President
Director and President of Subsidiary
$107,500
$159,708
$0
$267,208
$267,208
Director and President of Subsidiary
Enzolytics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2010. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us